Cost-utility analysis of palivizumab in Italy: results from a simulation model in the prophylaxis of respiratory syncytial virus infection (RSV) among high-risk preterm infants
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1824-7288
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Cost-utility analysis of palivizumab in Italy: results from a simulation model in the prophylaxis of respiratory syncytial virus infection (RSV) among high-risk preterm infants ; volume:35 ; number:1 ; day:25 ; month:2 ; year:2009 ; pages:1-12 ; date:12.2009
The Italian journal of pediatrics ; 35, Heft 1 (25.2.2009), 1-12, 12.2009
- Creator
-
Chirico, Gaetano
- Contributor
-
Ravasio, Roberto
Sbarigia, Urbano
SpringerLink (Online service)
- DOI
-
10.1186/1824-7288-35-4
- URN
-
urn:nbn:de:1111-2016032339186
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:53 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Chirico, Gaetano
- Ravasio, Roberto
- Sbarigia, Urbano
- SpringerLink (Online service)
Other Objects (12)
A cost-effectiveness analysis of respiratory syncytial virus (RSV) prophylaxis in infants in the United Kingdom /
Review of the home care programmes for respiratory syncytial virus (RSV) prophylaxis in Ireland and The Netherlands
Das Respiratory Syncytial Virus (RSV): Epidemiologie, Klinik- und Labordiagnose
Cost-utility analysis of Palivizumab for Respiratory Syncytial Virus infection prophylaxis in preterm infants: update based on the clinical evidence in Spain
Respiratory-Syncytial-Virus (RSV)-induzierte unspezifische bronchiale Hyperreaktivität : tierexperimentelle Untersuchungen am Meerschweinchen
Antikörper-Entwicklung nach Respiratory-Syncytial-Virus-(RSV)-Infektion bei Frühgeborenen und Säuglingen
Sucrose stabilization of Respiratory Syncytial Virus (RSV) during nebulization and experimental infection
Antikörper-Entwicklung nach Respiratory-Syncytial-Virus-(RSV)-Infektion bei Frühgeborenen und Säuglingen
Defining the timing of respiratory syncytial virus (RSV) outbreaks: an epidemiological study
Funktionelle Bedeutung der Infektion von T-Lymphozyten durch Respiratorisches Syncytial Virus (RSV)
Burden of respiratory syncytial virus (RSV) infection in Germany: a systematic review
Untersuchungen zur Struktur und Funktion des Glykoproteins G des Respiratory Syncytial Virus (RSV)
A cost-effectiveness analysis of respiratory syncytial virus (RSV) prophylaxis in infants in the United Kingdom /
Review of the home care programmes for respiratory syncytial virus (RSV) prophylaxis in Ireland and The Netherlands
Das Respiratory Syncytial Virus (RSV): Epidemiologie, Klinik- und Labordiagnose
Cost-utility analysis of Palivizumab for Respiratory Syncytial Virus infection prophylaxis in preterm infants: update based on the clinical evidence in Spain
Respiratory-Syncytial-Virus (RSV)-induzierte unspezifische bronchiale Hyperreaktivität : tierexperimentelle Untersuchungen am Meerschweinchen
Antikörper-Entwicklung nach Respiratory-Syncytial-Virus-(RSV)-Infektion bei Frühgeborenen und Säuglingen
Sucrose stabilization of Respiratory Syncytial Virus (RSV) during nebulization and experimental infection
Antikörper-Entwicklung nach Respiratory-Syncytial-Virus-(RSV)-Infektion bei Frühgeborenen und Säuglingen
Defining the timing of respiratory syncytial virus (RSV) outbreaks: an epidemiological study
Funktionelle Bedeutung der Infektion von T-Lymphozyten durch Respiratorisches Syncytial Virus (RSV)
Burden of respiratory syncytial virus (RSV) infection in Germany: a systematic review
Untersuchungen zur Struktur und Funktion des Glykoproteins G des Respiratory Syncytial Virus (RSV)
A cost-effectiveness analysis of respiratory syncytial virus (RSV) prophylaxis in infants in the United Kingdom /
Review of the home care programmes for respiratory syncytial virus (RSV) prophylaxis in Ireland and The Netherlands
Das Respiratory Syncytial Virus (RSV): Epidemiologie, Klinik- und Labordiagnose
Cost-utility analysis of Palivizumab for Respiratory Syncytial Virus infection prophylaxis in preterm infants: update based on the clinical evidence in Spain
Respiratory-Syncytial-Virus (RSV)-induzierte unspezifische bronchiale Hyperreaktivität : tierexperimentelle Untersuchungen am Meerschweinchen
Antikörper-Entwicklung nach Respiratory-Syncytial-Virus-(RSV)-Infektion bei Frühgeborenen und Säuglingen
Sucrose stabilization of Respiratory Syncytial Virus (RSV) during nebulization and experimental infection
Antikörper-Entwicklung nach Respiratory-Syncytial-Virus-(RSV)-Infektion bei Frühgeborenen und Säuglingen
Defining the timing of respiratory syncytial virus (RSV) outbreaks: an epidemiological study
Funktionelle Bedeutung der Infektion von T-Lymphozyten durch Respiratorisches Syncytial Virus (RSV)
Burden of respiratory syncytial virus (RSV) infection in Germany: a systematic review